- Home
- EXAS vs CLH Comparison
EXAS vs CLH Comparison
Compare EXAS & CLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- CLH
- Stock Information
- Founded
- EXAS 1995
- CLH 1980
- Country
- EXAS United States
- CLH United States
- Employees
- EXAS N/A
- CLH N/A
- Industry
- EXAS Medical Specialities
- CLH Environmental Services
- Sector
- EXAS Health Care
- CLH Industrials
- Exchange
- EXAS Nasdaq
- CLH Nasdaq
- Market Cap
- EXAS 10.7B
- CLH 10.3B
- IPO Year
- EXAS N/A
- CLH 1987
- Fundamental
- Price
- EXAS $56.13
- CLH $225.85
- Analyst Decision
- EXAS Strong Buy
- CLH Buy
- Analyst Count
- EXAS 20
- CLH 8
- Target Price
- EXAS $70.68
- CLH $249.25
- AVG Volume (30 Days)
- EXAS 3.3M
- CLH 269.9K
- Earning Date
- EXAS 07-30-2025
- CLH 04-30-2025
- Dividend Yield
- EXAS N/A
- CLH N/A
- EPS Growth
- EXAS N/A
- CLH 4.50
- EPS
- EXAS N/A
- CLH 7.22
- Revenue
- EXAS $2,828,128,000.00
- CLH $5,945,207,000.00
- Revenue This Year
- EXAS $14.58
- CLH $4.91
- Revenue Next Year
- EXAS $12.75
- CLH $5.37
- P/E Ratio
- EXAS N/A
- CLH $31.34
- Revenue Growth
- EXAS 11.57
- CLH 8.52
- 52 Week Low
- EXAS $39.97
- CLH $178.29
- 52 Week High
- EXAS $72.83
- CLH $267.11
- Technical
- Relative Strength Index (RSI)
- EXAS 60.75
- CLH 55.45
- Support Level
- EXAS $55.26
- CLH $223.76
- Resistance Level
- EXAS $58.68
- CLH $227.38
- Average True Range (ATR)
- EXAS 1.99
- CLH 3.33
- MACD
- EXAS -0.27
- CLH -1.32
- Stochastic Oscillator
- EXAS 62.66
- CLH 17.87
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.